Barings’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-4,109
Closed -$330K 612
2020
Q2
$330K Hold
4,109
0.01% 443
2020
Q1
$330K Hold
4,109
0.01% 443
2019
Q4
$437K Sell
4,109
-805
-16% -$83.9K 0.01% 482
2019
Q3
$526K Hold
4,914
0.01% 486
2019
Q2
$500K Buy
4,914
+960
+24% +$92.3K 0.01% 505
2019
Q1
$356K Hold
3,954
0.01% 596
2018
Q4
$329K Hold
3,954
0.01% 582
2018
Q3
$427K Hold
3,954
0.01% 652
2018
Q2
$435K Sell
3,954
-2,060
-34% -$215K 0.01% 676
2018
Q1
$603K Hold
6,014
0.01% 641
2017
Q4
$592K Hold
6,014
0.01% 657
2017
Q3
$563K Hold
6,014
0.01% 619
2017
Q2
$669K Sell
6,014
-14,673
-71% -$1.55M 0.02% 558
2017
Q1
$2.03M Buy
20,687
+15,043
+267% +$1.43M 0.04% 349
2016
Q4
$519K Buy
5,644
+1,000
+22% +$86.2K 0.01% 613
2016
Q3
$393K Hold
4,644
0.01% 632
2016
Q2
$378K Hold
4,644
0.01% 715
2016
Q1
$332K Sell
4,644
-6,400
-58% -$429K 0.01% 790
2015
Q4
$786K Hold
11,044
0.02% 545
2015
Q3
$679K Sell
11,044
-8,900
-45% -$622K 0.02% 557
2015
Q2
$1.45M Sell
19,944
-8,100
-29% -$598K 0.04% 401
2015
Q1
$2.15M Buy
28,044
+18,100
+182% +$1.3M 0.05% 308
2014
Q4
$667K Hold
9,944
0.01% 584
2014
Q3
$603K Hold
9,944
0.01% 613
2014
Q2
$584K Buy
9,944
+200
+2% +$11.7K 0.02% 661
2014
Q1
$564K Hold
9,744
0.02% 629
2013
Q4
$522K Buy
9,744
+3,200
+49% +$190K 0.02% 602
2013
Q3
$404K Sell
6,544
-600
-8% -$35.9K 0.02% 683
2013
Q2
$433K Buy
+7,144
New +$426K 0.02% 628

Other funds holding DGX

Barings's DGX Position: Q3 2020 in Review

Barings sold out of Quest Diagnostics (DGX) in Q3 2020, closing a stake of 4,109 shares — an estimated $330K sold.

Barings first reported a position in DGX in Q2 2013 and held it in 29 quarters. The position peaked at $2.15M in Q1 2015. 758 funds tracked by Wall St. Rank hold DGX as of Q3 2020.

  • Barings reported no remaining Quest Diagnostics position as of Q3 2020 after selling out during the quarter.
  • Barings sold 4,109 Quest Diagnostics shares in Q3 2020, an estimated $330K.
  • Barings first reported a position in Quest Diagnostics in Q2 2013 and held it in 29 quarters.
  • Barings's Quest Diagnostics position peaked at $2.15M in Q1 2015.
  • 758 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2020.

Based on Barings's 13F filing for Q3 2020, filed 12 Nov 2020.